Literature DB >> 18374879

A less invasive approach to axial flow pump insertion.

Igor D Gregoric1, Saverio La Francesca, Tim Myers, William Cohn, Pranav Loyalka, Biswajit Kar, Courtney Gemmato, O H Frazier.   

Abstract

BACKGROUND: Implantation of a HeartMate II or a Jarvik 2000 FlowMaker left ventricular assist system (LVAS) usually involves a mid-line sternotomy and the use of cardiopulmonary bypass (CPB). In patients with numerous co-morbid conditions, however, surgical trauma may be minimized by implanting the LVAS via a minimally invasive approach, preferably without CPB.
METHODS: In 6 patients with end-stage heart failure and other serious co-morbidities, we implanted a HeartMate II (n = 3) or a Jarvik 2000 FlowMaker (n = 3) LVAS via a right mini-thoracotomy and a left sub-costal incision. Patients included 3 men and 3 women with a mean age of 41 years. In 3 cases, the LVAS was implanted without CPB.
RESULTS: After a mean follow-up period of 6 months, 5 patients are alive and well and on the transplant waiting list. Seven months after LVAS implantation, the remaining patient developed a hemorrhagic stroke necessitating Jarvik 2000 replacement with a new pump of the same type.
CONCLUSIONS: In this small series, the combined sub-costal and mini-thoracotomy incision proved safe and technically feasible. It may be useful for other LVAS candidates who have serious co-morbidities that preclude traditional implant operations.

Entities:  

Mesh:

Year:  2008        PMID: 18374879     DOI: 10.1016/j.healun.2008.01.002

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

Review 1.  Minimally invasive is the future of left ventricular assist device implantation.

Authors:  George Makdisi; I-Wen Wang
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  How to do it: tips and tricks of minimal-invasive HVAD® implantation-the lateral approach.

Authors:  Ezin Deniz; Anamika Chatterjee; Christina Feldmann; Jasmin S Hanke; Guenes Dogan; Dominik Berliner; Malakh L Shrestha; Axel Haverich; Jan D Schmitto
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Early feasibility testing and engineering development of a sutureless beating heart connector for left ventricular assist devices.

Authors:  Steven C Koenig; Jorge H Jimenez; Seth D West; Michael A Sobieski; Young Choi; Gretel Monreal; Guruprasad A Giridharan; Kevin G Soucy; Mark S Slaughter
Journal:  ASAIO J       Date:  2014 Nov-Dec       Impact factor: 2.872

4.  HeartMate II implantation technique that spares the sternum and ascending aorta.

Authors:  Masashi Kawabori; Chitaru Kurihara; Tadahisa Sugiura; Andrew B Civitello; Jeffrey A Morgan
Journal:  J Artif Organs       Date:  2018-05-21       Impact factor: 1.731

5.  Minimally invasive and alternative approaches for long-term LVAD placement: the Vanderbilt strategy.

Authors:  Simon Maltais; Mary E Davis; Nicholas Haglund
Journal:  Ann Cardiothorac Surg       Date:  2014-11

Review 6.  Miniaturization of mechanical circulatory support systems.

Authors:  Guruprasad A Giridharan; Thomas J Lee; Mickey Ising; Michael A Sobieski; Steven C Koenig; Laman A Gray; Mark S Slaughter
Journal:  Artif Organs       Date:  2012-08       Impact factor: 3.094

7.  Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach.

Authors:  Louis E Samuels; Elena Casanova-Ghosh; Roberto Rodriguez; Christopher Droogan
Journal:  J Cardiothorac Surg       Date:  2012-03-12       Impact factor: 1.637

Review 8.  Minimally-invasive LVAD Implantation: State of the Art.

Authors:  Jasmin S Hanke; Sebastian V Rojas; Murat Avsar; Axel Haverich; Jan D Schmitto
Journal:  Curr Cardiol Rev       Date:  2015

Review 9.  Minimally invasive ventricular assist device implantation.

Authors:  Ameen Al-Naamani; Florian Fahr; Asim Khan; Christian Bireta; Michael Nozdrzykowski; Stefan Feder; Nikhil Deshmukh; Manal Jubeh; Sandra Eifert; Khalil Jawad; Uwe Schulz; Michael A Borger; Diyar Saeed
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.